Literature DB >> 9988847

Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome.

D Gothelf1, A Frisch, H Munitz, R Rockah, N Laufer, T Mozes, H Hermesh, A Weizman, M Frydman.   

Abstract

Velo-cardio-facial syndrome (VCFS) is caused by a microdeletion in the long arm of chromosome 22 and is associated with an increased frequency of schizophrenia and bipolar mood disorder. The purpose of this study was to investigate the genetic, physical, developmental and psychiatric features of schizophrenic patients with VCFS microdeletion. It describes the clinical findings in four schizophrenic inpatients with the characteristic chromosomal deletion. The four patients displayed delayed motor development, language deficits, learning disabilities, mental retardation, early age of onset, chronic and disabling course of illness and poor response to classical neuroleptic drugs and electroconvulsive therapy. Two patients benefited from treatment with clozapine. We suggest that schizophrenic patients with a history of delayed motor development, early onset of the disorder, history of learning disability, mental retardation, congenital cardiac anomalies and/or hypernasal speech should be screened for the velo-cardio-facial syndrome deletion. The implications of this study for psychiatric phenotype, nosology, disease mechanism, and possible new treatments in the future are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 9988847     DOI: 10.1016/s0920-9964(98)00114-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Response to clozapine in psychosis associated with velo-cardio-facial syndrome.

Authors:  Adeeb Yacoub; Maria Aybar
Journal:  Psychiatry (Edgmont)       Date:  2007-05

2.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

Review 3.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

Review 4.  Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.

Authors:  Prakash Devaraju; Stanislav S Zakharenko
Journal:  Bioessays       Date:  2017-01-03       Impact factor: 4.345

5.  A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.

Authors:  Noboru Hiroi; Hongwen Zhu; Moonsook Lee; Birgit Funke; Makoto Arai; Masanari Itokawa; Raju Kucherlapati; Bernice Morrow; Takehito Sawamura; Soh Agatsuma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

6.  Commentary on Treatment Resistant Psychosis in an adolescent with scoliosis and a history of early feeding difficulties.

Authors:  Andrea Stachon
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-02

7.  Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.

Authors:  Sungkun Chun; Fei Du; Joby J Westmoreland; Seung Baek Han; Yong-Dong Wang; Donnie Eddins; Ildar T Bayazitov; Prakash Devaraju; Jing Yu; Marcia M Mellado Lagarde; Kara Anderson; Stanislav S Zakharenko
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

8.  Response to clozapine in a clinically identifiable subtype of schizophrenia.

Authors:  Nancy J Butcher; Wai Lun Alan Fung; Laura Fitzpatrick; Alina Guna; Danielle M Andrade; Anthony E Lang; Eva W C Chow; Anne S Bassett
Journal:  Br J Psychiatry       Date:  2015-03-05       Impact factor: 9.319

9.  Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome.

Authors:  Arnaud Leleu; Guillaume Saucourt; Caroline Rigard; Gabrielle Chesnoy; Jean-Yves Baudouin; Massimiliano Rossi; Patrick Edery; Nicolas Franck; Caroline Demily
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-07-07       Impact factor: 4.785

10.  Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.

Authors:  Karen Zagursky; Ronald A Weller; Naushad Jessani; Jawwad Abbas; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.